HOME > Projects > Immunity and Regeneration Integration Unit

A-29

Immunity and Regeneration Integration Unit

6F

0613A

1. Understanding the pathogenesis of inflammatory skin diseases associated with dysbiosis
2. Analysis of the impact of maintaining skin homeostasis on overall health span

Our skin, the largest organ in the human body, protects us from the outside world. It also contains a diverse range of microorganisms that can impact our health. In particular, dysbiosis, which disrupts the normal bacterial flora, is known to occur in diseases such as acne vulgaris, atopic dermatitis, and psoriasis. However, the precise mechanism by which skin microorganisms affect the host's health and diseases is not well understood, and elucidating this could lead to the development of new treatments and preventative measures for skin diseases. Our laboratory employs cutting-edge analytical methods for the skin microbiome and host immunity, as well as 3D skin devices created from induced pluripotent stem cells, to analyze various inflammatory skin diseases and reveal new disease mechanisms, while also working on controlling pre-disease states to achieve "healthy skin."

Responsible Department

Department of Cutaneous Immunology and Microbiology

Research Partner

ROHTO Pharmaceutical Co., Ltd.

Project Members

Principal Investigator

FUJIMOTO Manabu

Professor

Department of Dermatology

Profile

 

MATSUOKA Yuumi

Professor

Immunology Frontier Research Center (IFReC)

Profile

Members

NAKAGAWA Seitaro

Specially Appointed Associate Professor
(Lecturer)

Department of Cutaneous Immunology and Microbiology

SUGIHIRA Takashi

Joint Research Collaborator

ROHTO Pharmaceutical Co., Ltd.

HOSHINO Natsuko

Joint Research Collaborator

ROHTO Pharmaceutical Co., Ltd.

←back